{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:53:08Z","timestamp":1760266388859},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.jbspin.2003.07.004","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T17:18:05Z","timestamp":1066151885000},"page":"433-447","source":"Crossref","is-referenced-by-count":12,"title":["Evaluating inflammatory joint disease: how and when can autoantibodies help?"],"prefix":"10.1016","volume":"70","author":[{"given":"Olivier","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2003.07.004_BIB1","first-page":"329","article-title":"Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction","volume":"47","year":"2002","journal-title":"Arthritis Rheum [Arthritis Care Res]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1169-8330(01)00268-X","article-title":"Les facteurs rhumato\u00efdes sont-ils utiles au diagnostic nosologique d\u2019un rhumatisme inflammatoire \u00e9voluant depuis moins de 12\u00a0mois en l\u2019absence de signes cliniques d\u2019orientation?","volume":"69","author":"Vittecoq","year":"2002","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.10241","article-title":"Value of laboratory tests in early prediction of rheumatoid arthritis","volume":"47","author":"Saraux","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1169-8330(01)00266-6","article-title":"Performances des crit\u00e8res 1987 de polyarthrite rhumato\u00efde de l\u2019American College of Rheumatology dans le contexte des arthrites d\u00e9butantes: \u00e9tude de la litt\u00e9rature","volume":"69","author":"Berthelot","year":"2002","journal-title":"Rev Rhum [ed Fr]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB5","first-page":"51","article-title":"Les auto-anticorps devant un rhumatisme inflammatoire d\u00e9butant","author":"Meyer","year":"2001"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansdky","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB8","first-page":"2074","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis inpatients with early arthritis","volume":"29","author":"Jansen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB9","first-page":"2324","article-title":"The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis","volume":"25","author":"Harrison","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB10","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S","article-title":"Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients 2\u00a0years later","volume":"44","author":"Saraux","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/rheumatology\/35.7.620","article-title":"Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor","volume":"35","author":"Cordonnier","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/03009749309095137","article-title":"Prospect for an additional laboratory criterion for rheumatoid arthritis","volume":"22","author":"Von Essen","year":"1993","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.152.12.2417","article-title":"How useful is the rheumatoid factor? An analysis of sensitivity, specificity and predictive value","volume":"152","author":"Schmerling","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB14","first-page":"16","article-title":"How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis?","volume":"62","author":"Saraux","year":"1995","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9343(91)90190-9","article-title":"The rheumatoid factor: an analysis of clinical utility","volume":"91","author":"Shmerling","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1169-8330(01)00002-3","volume":"68","author":"Vittecoq","year":"2001","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/art.1780340804","article-title":"The latex test revisited. Rheumatoid factor testing in 8287\u00a0rheumatic disease patients","volume":"34","author":"Wolfe","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002960050069","article-title":"Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis","volume":"18","author":"Jonsson","year":"1998","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.56.2.123","article-title":"Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled","volume":"56","author":"Berthelot","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB20","first-page":"1037","article-title":"Routine measurement of IgM, IgG and IgA rheumatoid factors: high sensitivity, specificity and predictive value for rheumatoid arthritis","volume":"24","author":"Swedler","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.55.3.157","article-title":"Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis","volume":"55","author":"Visser","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB22","first-page":"9","article-title":"Valeur des anticorps anti-p\u00e9rinucl\u00e9aires au 1:100 pour le diagnostic de polyarthrite rhumato\u00efde. Etude de 600\u00a0patients et m\u00e9ta-analyse de la litt\u00e9rature","volume":"65","author":"Berthelot","year":"1998","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB23","first-page":"299","article-title":"The antiperinuclear factor (APF) and antikeratin antibodies (AKA) in rheumatoid arthritis","author":"Hoet","year":"1992"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB24","first-page":"1278","article-title":"Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process","volume":"20","author":"Aho","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB25","first-page":"2056","article-title":"Antiperinuclear factor and antikeratin antibody: diagnostic use in a clinical laboratory setting","volume":"27","author":"Alnigenis","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ard.58.1.42","article-title":"Anti-perinuclear factor compared with the so called \u201cantikeratin\u201d antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritis","volume":"58","author":"Vincent","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB27","first-page":"689","article-title":"The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis","volume":"17","author":"Van Jaarsveld","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/030097400447714","article-title":"Antifilaggrin autoantibodies in early rheumatoid arthritis","volume":"29","author":"Forslind","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/030097499442586","article-title":"Antifilaggrin antibodies in recent-onset arthritis","volume":"28","author":"Aho","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB30","first-page":"699","article-title":"Etude de la pr\u00e9cocit\u00e9 d\u2019apparition des anticorps antik\u00e9ratine","volume":"53","author":"Le Goff","year":"1986","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB31","first-page":"601","article-title":"Les anticorps anti-k\u00e9ratine. Un marqueur des polyarthrites rhumato\u00efdes \u00e9volutives","volume":"53","author":"Meyer","year":"1986","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB32","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.60.1.32","article-title":"Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis","volume":"60","author":"Paimela","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.10229","article-title":"Identification of citrullinated rheumatoid arthritis\u2014specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay","volume":"46","author":"Union","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB35","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/art.10436","article-title":"Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay. A highly effective test for the diagnosis of rheumatoid arthritis","volume":"46","author":"Vincent","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1169-8330(01)00131-4","article-title":"Autoanticorps antifilaggrine\/antifibrine d\u00e9imin\u00e9e. Outre leur int\u00e9r\u00eat diagnostique et pronostique, les autoanticorps antifilaggrine\/antifibrine d\u00e9imin\u00e9e (AFA) sont probablement impliqu\u00e9s dans la physiopathog\u00e9nie rhumato\u00efde","volume":"68","author":"Serre","year":"2001","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB37","first-page":"838","article-title":"Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis","volume":"25","author":"Vincent","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000069460","article-title":"Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay","volume":"115","author":"Palosuo","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/ar122","article-title":"Insights into rheumatoid arthritis derived from the Sa immune system","volume":"2","author":"Menard","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB41","first-page":"7","article-title":"Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis","volume":"26","author":"Hayem","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/rheumatology\/38.2.155","article-title":"Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis","volume":"38","author":"Hueber","year":"1999","journal-title":"Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB43","first-page":"1027","article-title":"The Sa system: a novel antigen\u2013antibody system specific for rheumatoid arthritis","volume":"21","author":"Despr\u00e8s","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB44","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","article-title":"Demonstration of a new antinuclear antibody (anti-RA 33) that is highly specific for rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/32.3.199","article-title":"Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB46","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1172\/JCI117870","article-title":"Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera","volume":"95","author":"Despr\u00e9s","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB47","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1073\/pnas.92.16.7267","article-title":"Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases","volume":"92","author":"Mimori","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4065\/70.2.183","article-title":"Cascade testing for autoantibodies in connective tissue diseases","volume":"70","author":"Homburger","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB49","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB50","first-page":"914","article-title":"The distribution of antinuclear antibody titers in \u201cnormal\u201d children and adults","volume":"26","author":"Craig","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB51","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/art.1780400910","article-title":"Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays","volume":"40","author":"Emlen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.10558","article-title":"Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests","volume":"47","author":"Kavanaugh","year":"2002","journal-title":"Arthritis Rheum [Arthritis Care Res]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum [Arthritis Care Res]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB54","first-page":"294","article-title":"Detection of antibodies to dsDNA: current insights into its relevance","volume":"20","author":"Smeenk","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I","article-title":"Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus","volume":"43","author":"Amoura","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB56","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/art.1780381015","article-title":"Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus","volume":"38","author":"Chabre","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1529-0131(200201)46:1<280::AID-ART10079>3.0.CO;2-A","article-title":"Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al","volume":"46","author":"Ben Hadj Hmida","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB58","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO;2-J","article-title":"Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus","volume":"43","author":"Bruns","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB59","first-page":"S379","article-title":"Diagnostic value of nucleosome specific antibodies in recent active non treated SLE","volume":"43","author":"Goetz","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB60","first-page":"2226","article-title":"The evolution of Raynaud\u2019s phenomenon: a long-term prospective study","volume":"22","author":"Luggen","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70 and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum [Arthritis Care Res]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB62","first-page":"425","article-title":"Les anticorps anticentrom\u00e8re en pratique rhumatologique ne sont pas toujours associ\u00e9s \u00e0 une scl\u00e9rodermie","volume":"64","author":"Tubach","year":"1997","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB63","first-page":"313","article-title":"Five-year follow-up of 665\u00a0Hungarian patients with undifferentiated connective tissue disease (UCTD)","volume":"21","author":"Bodolay","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB64","first-page":"615","article-title":"Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria","volume":"17","author":"Mosca","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB65","first-page":"585","article-title":"Five-year follow-up of 165\u00a0Italian patients with undifferentiated connective tissue diseases","volume":"17","author":"Danieli","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB66","first-page":"403","article-title":"Undifferentiated connective tissue disease with antibodies to Ro\/SSA: clinical features and follow-up of 148\u00a0patients","volume":"19","author":"Cavazzana","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-1759(90)90362-Y","article-title":"The detection of anti-Ro\/SSA and anti-La\/SSB antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays","volume":"133","author":"Meilof","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB68","first-page":"729","article-title":"Comparison of different methods for the detection of anti-Ro\/SSA antibodies in connective tissue disease","volume":"18","author":"Morozzi","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/32.6.449","article-title":"Detection of anti-Ro (SSA) antibodies in autoimmune diseases: comparison of five methods","volume":"32","author":"Manoussakis","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3","article-title":"A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity and specificity","volume":"42","author":"Tan","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/030097400750001923","article-title":"Ro 52\u00a0kDa autoantibodies are detected in a subset of ANA-negative sera","volume":"29","author":"Pourmand","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB72","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.61.12.1090","article-title":"Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB74","first-page":"533","article-title":"Isolated congenital complete heart block: long-term outcome of mothers, maternal antibody specificity and immunogenetic background","volume":"22","author":"Brucato","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB75","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/art.1780361114","article-title":"Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A\/Ro and to SS-B\/La","volume":"36","author":"Julkunen","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB76","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.61.10.929","article-title":"Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/art.1780330307","article-title":"Dissociation of immune responses to the SSA (Ro) 52\u00a0and 60\u00a0kDa polypeptides in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome","volume":"33","author":"Ben-Chetrit","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro 52\u00a0antibodies frequently co-occur with anti-J01 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-199505000-00001","article-title":"One hundred anti-Ro (SSA) antibody positive patients: a 10-year follow-up","volume":"74","author":"Simmons-O\u2019Brien","year":"1995","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB80","first-page":"91","article-title":"Signification clinique et biologique des anticorps anti-Ro\/SSA. Etude et suivi d\u2019un groupe de 127\u00a0patients avec anticorps anti-Ro\/SSA","author":"Sibilia","year":"1996"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB81","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB82","first-page":"181","article-title":"Anti-La (SSB): a diagnostic criterion for Sj\u00f6gren\u2019s syndrome?","volume":"7","author":"Venables","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB83","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0248-8663(00)89226-7","article-title":"Signification clinique des anticorps antiribosomes","volume":"21","author":"Johanet","year":"2000","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002281-200301000-00003","article-title":"Epidemiology of the vasculitides","volume":"15","author":"Watts","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB85","first-page":"845","article-title":"Les manifestations articulaires de la maladie de Wegener. A propos de 13\u00a0observations","volume":"57","author":"Alcalay","year":"1990","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB86","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-123-12-199512150-00005","article-title":"The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis","volume":"123","author":"Rao","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB87","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB88","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","article-title":"Test characteristics of immunofluorescence and ELISA tests in 856\u00a0consecutive patients with possible ANCA-associated conditions","volume":"13","author":"Stone","year":"2000","journal-title":"Arthritis Rheum [Arthritis Care Res]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB89","first-page":"1584","article-title":"Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies","volume":"28","author":"Choi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1169-8330(01)00267-8","article-title":"Int\u00e9r\u00eat du dosage des anticorps antinucl\u00e9aires, des anticorps antiphospholipides et des anticorps anticytoplasme des neutrophiles dans le diagnostic nosologique des rhumatismes inflammatoires chroniques d\u00e9butants sans signe clinique d\u2019orientation","volume":"69","author":"Hachulla","year":"2002","journal-title":"Rev Rhum [Ed Fr]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/qjmed\/94.11.615","article-title":"The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting","volume":"94","author":"McLaren","year":"2001","journal-title":"Q J Med"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB92","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(95)91555-9","article-title":"A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener\u2019s granulomatosis","volume":"346","author":"Rao","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB93","first-page":"1802","article-title":"Exclusion criteria for primary antiphospholipid syndrome","volume":"20","author":"Piette","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB94","first-page":"2131","article-title":"Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?","volume":"26","author":"Weber","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB95","first-page":"241","article-title":"Antibodies to cardiolipin and beta 2\u00a0glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis","volume":"63","author":"Meyer","year":"1996","journal-title":"Rev Rhum [Engl Ed]"},{"key":"10.1016\/j.jbspin.2003.07.004_BIB96","first-page":"13","article-title":"Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody","volume":"20","author":"Min","year":"2002","journal-title":"Clin Exp Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X03001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X03001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T04:22:03Z","timestamp":1550636523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X03001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1297319X03001817"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2003.07.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}